Ypsomed's autoinjector YpsoMate

Promising start-up opts for Ypsomed's user-friendly autoinjector to treat PMDD

YDS Story

Asarina Pharma has decided to go with our user-friendly two-step autoinjector YpsoMate for its commercial launch of its drug Sepranolone. Sepranolone is the world’s first treatment for pre-menstrual dysphoric disorder (PMDD).

Ypsomed's heat pump

Ypsomed is committed to circular economy

YpsoStory

As a responsible and innovative company, Ypsomed has committed itself to the concept of circular economy. It is our goal to set a good example as a sustainable company in the medtech industry.

Topics:
Responsibility & Engagement

Ysomed's production site in Schwerin

Ultra-modern production plant for injection and infusion systems has started well

YpsoStory

At the end of August, we ceremoniously opened our new state-of-the-art production plant in Schwerin, in North-East Germany. The production got off to a good start. Today, three months later, a perfectly tuned team is at work.

Topics:
Platforms & Operational Excellence

YpsoDose patch injector in use

Satisfied user study participants

YDS Story

YpsoDose is a patch injector for large volumes. When developing YpsoDose, we focus on user-friendliness as we do with all our injection systems. The latest user studies have confirmed how easy YpsoDose is to use. 

Adolescents at Ypsomed

An important day for Ypsomed

YpsoStory

November 14 is a day of great importance for Ypsomed. Today is World Diabetes Day as well as National Future Day in Switzerland, where our headquarters are located. Today, we have the opportunity to draw attention to diabetes and to equality.

Topics:
Responsibility & Engagement